SavedAdd your journal

Journals / art / 2014 / Cilt: 29 - Sayı: 1

Reactive arthritis following ıntravesical ınstillation of bacillus calmette-guerin

Selin HASSAN
Peyman YALÇIN
Şebnem ATAMAN
Nurban SÜLDÜR
Journal
art
Pages
61–64
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, we present a 64-year- old male case who developed reactive arthritis with fever and asymmetric oligoarthritis following treatment with intravesical Bacillus Calmette-Guerin (BCG) for bladder carcinoma.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Reactive arthritis is a seronegative, HLA-B27-linked spondyloarthropathy which occurs as a result of a pathogen, often of gastrointestinal or genitourinary origin, and triggers a cell-mediated immune response.
📊
Key Findings & Data:Reactive arthritis is a seronegative, HLA-B27-linked spondyloarthropathy which occurs as a result of a pathogen, often of gastrointestinal or genitourinary origin, and triggers a cell-mediated immune response.
💡
Conclusion & Impact:In this article, we present a 64-year- old male case who developed reactive arthritis with fever and asymmetric oligoarthritis following treatment with intravesical Bacillus Calmette-Guerin (BCG) for bladder carcinoma.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Reactive arthritis is a seronegative, HLA-B27-linked spondyloarthropathy which occurs as a result of a pathogen, often of gastrointestinal or genitourinary origin, and triggers a cell-mediated immune response. In this article, we present a 64-year- old male case who developed reactive arthritis with fever and asymmetric oligoarthritis following treatment with intravesical Bacillus Calmette-Guerin (BCG) for bladder carcinoma.

🔖

Cite This Article

HASSAN, S., YALÇIN, P., ATAMAN, Ş., SÜLDÜR, N. (2014). Reactive arthritis following ıntravesical ınstillation of bacillus calmette-guerin. art, Cilt: 29 - Sayı: 1, 61–64. https://ajindex.com/articles/351753

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Repo ML, Koivuniemi R, Breban M. Infections and arthritis. In. Bijlsma JWJ, editor. EULAR textbook on rheumatic diseases. 1st ed. London: BMJ Group; 2012. p. 335–6. 2 Carter JD. Reactive arthritis: defined etiologies, emerging pathophysiology, and unresolved treatment. Infect Dis Clin North Am 2006;20:827–47. 3. Harms RW, Berge KG, Hagen PT, Litin SC, Sheps SG. Reactive arthritis. Mayo Clinic [serial online] 2011. Accessed 06/06/2012. Available from: http://www. mayoclinic.com/health/reactive-arthritis/DS00486 4. Kim JY, Lee JH, Yoon IeN. Macular infarction associated with reactive arthritis. Korean J Ophthalmol 2010;24:310–3. 5. Alexandroff AB, Jackson AM, O’Donnell MA, James K. BCG immunotherapy of bladder cancer: 20 years on. Lancet 1999;353:1689–94. 6. Librenjak D, Novaković ZS, Milostić K. Carcinoma in situ of urinary bladder: incidence, treatment and clinical outcomes during ten-year follow-up. Acta Clin Croat 2012;51:201–7. 7. Clavel G, Grados F, Lefauveau P, Fardellone P. Osteoarticular side effects of BCG therapy. Joint Bone Spine 2006;73:24–8. 8. Tinazzi E, Ficarra V, Simeoni S, Artibani W, Lunardi C. Reactive arthritis following BCG immunotherapy for urinary bladder carcinoma: a systematic review. Rheumatol Int 2006;26:481–8. 9. Pardalidis NP, Papatsoris AG, Kosmaoglou EV, Georganas C. Two cases of acute polyarthritis secondary to intravesical BCG adjuvant therapy for superficial bladder cancer. Clin Rheumatol 2002;21:536–7. 10. Carter JD. Treating reactive arthritis: insights for the clinician. Ther Adv Musculoskelet Dis 2010;2:45–54.